Musculoskeletal and joint disease

Western Devon Health Community Shared Care Guidelines - Musculoskeletal and joint disease

Click on the links below to access individual guidelines.   
Denosumab (Prolia®) for osteoporosis (November 2016) DMARDs for rheumatological conditions (November 2018)

Click on the following link to access separate prescribing guidelines on the use of DMARDs in gastroenterology, haematology and renal patients

Click on the following link to access separate prescribing guidelines on the use of DMARDs in dermatological conditions 

The following guidelines are currently under review. In the interim, the guidelines remain valid; if GPs have any specific concerns or questions, they should seek advice from the specialist with whom they have agreed to share care.
Cyclophosphamide - rheumatological conditions Hydroxychloroquine for the treatment of rheumatoid arthritis and systemic lupus erythematosus

Rate this page